| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 419 | 1.039 | 19.883 | 67.604 | 118.557 | 163.317 | 272.665 |
| Total Income - EUR | - | - | - | 419 | 1.039 | 19.887 | 67.875 | 119.399 | 165.502 | 273.607 |
| Total Expenses - EUR | - | - | - | 560 | 5.798 | 9.134 | 35.811 | 85.136 | 104.449 | 190.132 |
| Gross Profit/Loss - EUR | - | - | - | -141 | -4.759 | 10.753 | 32.064 | 34.263 | 61.053 | 83.475 |
| Net Profit/Loss - EUR | - | - | - | -154 | -4.790 | 10.386 | 30.980 | 33.238 | 59.484 | 75.678 |
| Employees | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 5 |
Check the financial reports for the company - Neurobrain Cliniq S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 78 | 2.401 | 35.719 | 31.917 | 325.589 | 333.196 | 412.832 |
| Current Assets | - | - | - | 471 | 710 | 7.243 | 5.756 | -48.763 | -38.476 | 34.603 |
| Inventories | - | - | - | 0 | 25 | 0 | 0 | 68 | 616 | 603 |
| Receivables | - | - | - | 32 | 625 | 1.103 | 3.638 | 4.216 | 6.040 | 45.456 |
| Cash | - | - | - | 439 | 60 | 6.141 | 2.118 | -53.047 | -45.132 | -11.456 |
| Shareholders Funds | - | - | - | -111 | -4.899 | 5.580 | 31.029 | 63.349 | 69.977 | 76.059 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 660 | 12.391 | 42.747 | 11.745 | 229.140 | 228.482 | 371.787 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurobrain Cliniq S.r.l.